Cancer Gene Therapy Market Size, Share, Trends, Growth Outlook

Cancer Gene Therapy Market is estimated to increase at a growth rate of 20.3% CAGR over the forecast period from 2024 to 2030.

The Cancer Gene Therapy Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Therapy (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer), By End-User (Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Others).

An Introduction to Cancer Gene Therapy Market in 2024

The Cancer Gene Therapy market in 2024 showcases innovative approaches to cancer treatment, leveraging genetic engineering techniques to target and modulate cancer cell behavior. Gene therapy interventions, including oncolytic viruses, gene editing technologies, and gene transfer vectors, aim to selectively kill cancer cells, suppress tumor growth, or enhance the immune system's anti-cancer response. Market dynamics are shaped by factors such as advances in genomics, increasing availability of gene delivery platforms, and clinical trial successes demonstrating the therapeutic potential of gene-based cancer treatments. Collaboration between molecular biologists, oncologists, gene therapy developers, and regulatory authorities drives innovation and translation of gene therapy approaches into clinical practice, offering new hope for cancer patients.

Cancer Gene Therapy Market Trend: Advancements in Gene Editing Technologies

A prominent trend in the Cancer Gene Therapy market is the continuous advancements in gene editing technologies. Emerging techniques such as CRISPR-Cas9, TALENs, and zinc-finger nucleases enable precise modifications of the genome, offering unprecedented opportunities for targeted cancer therapies. These technologies allow researchers to edit, delete, or insert specific genes involved in cancer development, progression, and resistance, paving the way for more effective and personalized treatment approaches. As gene editing tools become more refined and accessible, they hold immense potential for enhancing the efficacy and safety of cancer gene therapies, driving innovation in the field.

Cancer Gene Therapy Market Driver: Growing Demand for Precision Medicine Solutions

The primary driver for the Cancer Gene Therapy market is the growing demand for precision medicine solutions. Traditional cancer treatments often lack specificity and can cause significant side effects due to their indiscriminate targeting of both healthy and cancerous cells. In contrast, gene therapy offers a highly precise and tailored approach by targeting the underlying genetic abnormalities driving cancer growth. With increasing emphasis on personalized medicine and the need to address treatment resistance and relapse, there is escalating interest in gene therapies that can selectively target cancer cells while sparing normal tissues. This demand is fueled by advancements in genomic profiling, biomarker identification, and molecular diagnostics, enabling clinicians to match patients with the most appropriate gene therapy interventions based on their genetic makeup and tumor characteristics.

Cancer Gene Therapy Market Opportunity: Expansion into Combination Therapies and Rare Cancer Types

An opportunity in the Cancer Gene Therapy market lies in the expansion into combination therapies and rare cancer types. While gene therapy holds promise as a standalone treatment modality, its full potential can be realized through synergistic combinations with other therapeutic approaches such as chemotherapy, radiation therapy, immunotherapy, and targeted therapies. Combination regimens can exploit complementary mechanisms of action, overcome treatment resistance, and enhance therapeutic outcomes for patients with diverse cancer types. Additionally, there is a significant unmet need for effective treatments for rare and genetically complex cancers, where conventional therapies have limited efficacy. By focusing on the development of gene therapies for rare cancer indications and leveraging their precision targeting capabilities, companies can address underserved patient populations and establish a competitive edge in the market.

Cancer Gene Therapy Market Segmentation

By Therapy
Oncolytic Virotherapy
Gene Induced Immunotherapy
Gene Transfer
By End-user
Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Cancer Gene Therapy Market Companies

Abeona Therapeutics Inc
Altor Bioscience Inc
Asklepios BioPharmaceutical Inc
BioCancell Inc
Bluebird bio Inc
CelgeneInc
Elevate BioInc
Genelux Corp
GenVec
GlaxoSmithKlineInc
Introgen TherapeuticsInc
MerckKGaA
OncoGenex Pharmaceuticals Inc

 

 

Reasons to Buy the Cancer Gene Therapy Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Cancer Gene Therapy Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Cancer Gene Therapy Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Cancer Gene Therapy Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Cancer Gene Therapy Market Size Outlook, $ Million, 2021 to 2030
3.2 Cancer Gene Therapy Market Outlook by Type, $ Million, 2021 to 2030
3.3 Cancer Gene Therapy Market Outlook by Product, $ Million, 2021 to 2030
3.4 Cancer Gene Therapy Market Outlook by Application, $ Million, 2021 to 2030
3.5 Cancer Gene Therapy Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Cancer Gene Therapy Market Industry
4.2 Key Market Trends in Cancer Gene Therapy Market Industry
4.3 Potential Opportunities in Cancer Gene Therapy Market Industry
4.4 Key Challenges in Cancer Gene Therapy Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Cancer Gene Therapy Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Cancer Gene Therapy Market Outlook By Segments
7.1 Cancer Gene Therapy Market Outlook by Segments
By Therapy
Oncolytic Virotherapy
Gene Induced Immunotherapy
Gene Transfer
By End-user
Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Others

8 North America Cancer Gene Therapy Market Analysis And Outlook To 2030
8.1 Introduction to North America Cancer Gene Therapy Markets in 2024
8.2 North America Cancer Gene Therapy Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Cancer Gene Therapy Market size Outlook by Segments, 2021-2030
By Therapy
Oncolytic Virotherapy
Gene Induced Immunotherapy
Gene Transfer
By End-user
Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Others

9 Europe Cancer Gene Therapy Market Analysis And Outlook To 2030
9.1 Introduction to Europe Cancer Gene Therapy Markets in 2024
9.2 Europe Cancer Gene Therapy Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Cancer Gene Therapy Market Size Outlook By Segments, 2021-2030
By Therapy
Oncolytic Virotherapy
Gene Induced Immunotherapy
Gene Transfer
By End-user
Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Others

10 Asia Pacific Cancer Gene Therapy Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Cancer Gene Therapy Markets in 2024
10.2 Asia Pacific Cancer Gene Therapy Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Cancer Gene Therapy Market size Outlook by Segments, 2021-2030
By Therapy
Oncolytic Virotherapy
Gene Induced Immunotherapy
Gene Transfer
By End-user
Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Others

11 South America Cancer Gene Therapy Market Analysis And Outlook To 2030
11.1 Introduction to South America Cancer Gene Therapy Markets in 2024
11.2 South America Cancer Gene Therapy Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Cancer Gene Therapy Market size Outlook by Segments, 2021-2030
By Therapy
Oncolytic Virotherapy
Gene Induced Immunotherapy
Gene Transfer
By End-user
Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Others

12 Middle East And Africa Cancer Gene Therapy Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Cancer Gene Therapy Markets in 2024
12.2 Middle East and Africa Cancer Gene Therapy Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Cancer Gene Therapy Market size Outlook by Segments, 2021-2030
By Therapy
Oncolytic Virotherapy
Gene Induced Immunotherapy
Gene Transfer
By End-user
Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abeona Therapeutics Inc
Altor Bioscience Inc
Asklepios BioPharmaceutical Inc
BioCancell Inc
Bluebird bio Inc
CelgeneInc
Elevate BioInc
Genelux Corp
GenVec
GlaxoSmithKlineInc
Introgen TherapeuticsInc
MerckKGaA
OncoGenex Pharmaceuticals Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Therapy
Oncolytic Virotherapy
Gene Induced Immunotherapy
Gene Transfer
By End-user
Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Others